Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
155 studies found for:    Open Studies | "Bile Duct Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Bile Duct Diseases" (155 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP
Conditions: Choledocholithiasis;   Bile Duct Diseases;   Bile Duct Carcinoma
Intervention: Other: "Air" contrast cholangiography using carbon dioxide gas
2 Recruiting Impact of Pinaverium Bromide on Bile Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography
Condition: Bile Duct Diseases
Interventions: Dietary Supplement: pinaverium bromide;   Dietary Supplement: Vitamin C
3 Unknown  Compare the Knob-tipped Knife With the Needle Knife in Difficult Biliary Cannulation
Conditions: Endoscopic Retrograde Cholangiopancreatography;   Bile Duct Diseases
Intervention: Procedure: Precut papillotomy
4 Recruiting Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis
Intervention:
5 Recruiting Single Agent Regorafenib in Refractory Advanced Biliary Cancers
Condition: Cancer of the Bile Duct
Intervention: Drug: Regorafenib
6 Recruiting Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
Conditions: Common Bile Duct Stone;   Malignant Hepatobiliary Neoplasm;   Biliary Stricture;   Pancreatic Diseases;   Sphincter of Oddi Dysfunction
Intervention: Device: cannulation of ampulla of Vater
7 Recruiting EUS Guided ERCP in Bile Duct Stone Removal
Condition: Choledocholithiasis
Interventions: Procedure: ERCP without the use of fluoroscopy;   Procedure: ERCP with the use of fluoroscopy
8 Recruiting Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction
Condition: Sphincter of Oddi Dysfunction
Interventions: Drug: Danshu Capsules;   Drug: Pinaverium Bromide
9 Recruiting Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla
Conditions: Common Bile Duct Gallstones;   Choledocholithiasis
Interventions: Procedure: Spyglass;   Procedure: Balloon dilation of the papilla;   Procedure: EHL (electrohydraulic lithotripsy);   Procedure: ERCP (Endoscopic retrograde cholangiopancreatography)
10 Recruiting Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements
Conditions: Gallstones;   Cholelithiasis;   Cholecystolithiasis;   Choledocholithiasis
Interventions: Procedure: endoscopic sphincterotomy;   Procedure: laparoscopic common bile duct exploration;   Procedure: laparoscopic transcystic common bile duct exploration;   Procedure: laparoscopic cholecystectomy
11 Recruiting Comparison of LCBDE vs ERCP + LC for Choledocholithiasis
Condition: Choledocholithiasis
Interventions: Procedure: Laparoscopy;   Procedure: Endoscopy
12 Unknown  Trial of Laparoscopic Cholecystectomy vs. Non-operative Treatment for Gallbladder Dyskinesia
Condition: Gallbladder Dyskinesia
Interventions: Procedure: Laparoscopic Cholecystectomy;   Drug: amitriptyline;   Other: low-fat and low cholesterol diet
13 Recruiting Laser Versus Mechanical Lithotripsy of Bile Duct Stones
Condition: Choledocholithiasis
Interventions: Procedure: Laser and mechanical lithotripsy;   Procedure: Mechanical Lithotripsy
14 Unknown  Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography).
Conditions: Bile Duct Stricture;   Choledocholithiasis
Intervention: Other: Blood draw for culture
15 Unknown  A Prospective Randomized Study Comparing Different Dilation Durations for Endoscopic Papillary Balloon Dilatation
Condition: Choledocholithiasis
Interventions: Procedure: Endoscopic papillary balloon dilation-5 minutes;   Procedure: Endoscopic papillary balloon dilation-1 minute
16 Unknown  Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis
Conditions: Choledocholithiasis;   Cholelithiasis
Interventions: Procedure: Laparoendoscopic Rendez vous;   Procedure: preoperative ERCP and CBD clearance
17 Recruiting Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
18 Recruiting Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
19 Recruiting NKT Role in the Regulation of the Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Diseases;   Primary Sclerosing Cholangitis
Intervention: Other: collection of gut biopsies collection of blood samples
20 Not yet recruiting Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Conditions: Non-Resectable Cholangiocarcinoma;   Recurrent Cholangiocarcinoma;   Stage III Extrahepatic Bile Duct Cancer;   Stage III Intrahepatic Cholangiocarcinoma;   Stage IIIA Hilar Cholangiocarcinoma;   Stage IIIB Hilar Cholangiocarcinoma;   Stage IVA Extrahepatic Bile Duct Cancer;   Stage IVA Hilar Cholangiocarcinoma;   Stage IVA Intrahepatic Cholangiocarcinoma;   Stage IVB Extrahepatic Bile Duct Cancer;   Stage IVB Hilar Cholangiocarcinoma;   Stage IVB Intrahepatic Cholangiocarcinoma;   Unresectable Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Ricolinostat

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years